Product Information
ROSUVASTATIN CALCIUM 40 MG TAB is a generic product labeled by ScieGen Pharmaceuticals, Inc., priced at $0.0686 per EA under NDC 50228011905. Its NADAC has been published 128 times since Mar 13, 2024.
FDA first approved this application on Apr 24, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40 mg/1
Manufacturer
ScieGen Pharmaceuticals, Inc.NDC
50228011905
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ROSUVASTATINApproval Type
Generic (ANDA)
FDA Application
ANDA206381FDA Approved
4/24/2019
TE Code
AB
On Market Since
4/24/2019
Pharmacological Classes
Price Statistics
The NADAC for ROSUVASTATIN CALCIUM 40 MG TAB has been published 128 times since Mar 13, 2024, and over the history we have for it it has declined 36.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0686 per EA |
|---|---|
| All-time high | $0.1134 (Apr 10, 2024) |
| All-time low | $0.0591 (Apr 22, 2026) |
| 52-week high | $0.0754 |
| 52-week low | $0.0591 |
| Median price | $0.0797 |
| Average price | $0.0808 |
| Largest weekly change | +25.6% (Aug 21, 2024) |
| Weeks tracked | 128 |
| Tracking since | Mar 13, 2024 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 9% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ROSUVASTATIN CALCIUM 40 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for ROSUVASTATIN CALCIUM 40 MG TAB, manufactured by ScieGen Pharmaceuticals, Inc., is $0.0686 per EA (NDC 50228011905), effective Aug 19, 2026.
How has the price of ROSUVASTATIN CALCIUM 40 MG TAB changed over time?
Over the history we have for it, the NADAC for ROSUVASTATIN CALCIUM 40 MG TAB has declined 36.7%. It has been tracked across 128 weekly CMS publications since Mar 13, 2024.
What are the highest and lowest recorded NADAC prices for ROSUVASTATIN CALCIUM 40 MG TAB?
Since Mar 13, 2024, the NADAC for ROSUVASTATIN CALCIUM 40 MG TAB has ranged from a low of $0.0591 (Apr 22, 2026) to a high of $0.1134 (Apr 10, 2024), with a median of $0.0797 per EA.
Are there cheaper alternatives to ROSUVASTATIN CALCIUM 40 MG TAB?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ROSUVASTATIN CALCIUM 40 MG TAB, is $0.0621 per EA — about 9% below ROSUVASTATIN CALCIUM 40 MG TAB.
Who manufactures ROSUVASTATIN CALCIUM 40 MG TAB?
ROSUVASTATIN CALCIUM 40 MG TAB (NDC 50228011905) is labeled by ScieGen Pharmaceuticals, Inc., and CMS classifies it as a generic product.